These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 19562695)

  • 1. Older donors: mounting risks for the hepatitis C-infected liver transplant recipient?
    Valadao RM; Terrault NA
    Liver Transpl; 2009 Jul; 15(7):677-81. PubMed ID: 19562695
    [No Abstract]   [Full Text] [Related]  

  • 2. Predictors of graft and patient survival in subjects undergoing transplantation for hepatitis C virus infection.
    Audimoolam VK; Foxton MR; Agarwal K; O'Grady JG; Heneghan MA
    Liver Transpl; 2010 Apr; 16(4):536-7. PubMed ID: 20373465
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of the donor risk index on the outcome of hepatitis C virus-positive liver transplant recipients.
    Maluf DG; Edwards EB; Stravitz RT; Kauffman HM
    Liver Transpl; 2009 Jun; 15(6):592-9. PubMed ID: 19479802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmission of human immunodeficiency virus and hepatitis C virus through liver transplantation.
    Ahn J; Cohen SM
    Liver Transpl; 2008 Nov; 14(11):1603-8. PubMed ID: 18975294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended donors in liver transplantation.
    Harring TR; O'Mahony CA; Goss JA
    Clin Liver Dis; 2011 Nov; 15(4):879-900. PubMed ID: 22032534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus-infected donors in liver transplantation.
    Peek R; Reddy KR
    Gastroenterology; 2007 Aug; 133(2):381-2. PubMed ID: 17681155
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of the donor liver with steatosis in patients with hepatitis C virus: not so FAst.
    Yilmaz N; Shiffman ML
    Liver Transpl; 2009 Jan; 15(1):4-6. PubMed ID: 19109836
    [No Abstract]   [Full Text] [Related]  

  • 8. The challenging patient: HCV and alcoholic liver disease.
    Lucey MR; Lake JR
    Liver Transpl; 2007 Nov; 13(11 Suppl 2):S87-8. PubMed ID: 17969072
    [No Abstract]   [Full Text] [Related]  

  • 9. Treating chronic hepatitis C virus after liver transplantation: balancing the risks against the chance for success.
    Shiffman ML
    Liver Transpl; 2007 Aug; 13(8):1088-91. PubMed ID: 17663409
    [No Abstract]   [Full Text] [Related]  

  • 10. Delayed domino liver transplantation: use of the remnant liver of a recipient of a temporary auxiliary orthotopic liver transplant as a liver graft for another patient.
    Hashikura Y; Ikegami T; Nakazawa Y; Urata K; Ogino S; Terada M; Miyagawa S; Kawasaki S; Takei Y; Ikeda S
    Transplantation; 2004 Jan; 77(2):324. PubMed ID: 14743007
    [No Abstract]   [Full Text] [Related]  

  • 11. Recipient age affects long-term outcome and hepatitis C recurrence in old donor livers following transplantation.
    Selzner M; Kashfi A; Selzner N; McCluskey S; Greig PD; Cattral MS; Levy GA; Lilly L; Renner EL; Therapondos G; Adcock LE; Grant DR; McGilvray ID
    Liver Transpl; 2009 Oct; 15(10):1288-95. PubMed ID: 19790152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Workgroup on expanded criteria organs for liver transplantation.
    New York State Department of Health Workgroup
    Liver Transpl; 2005 Oct; 11(10):1184-92. PubMed ID: 16184565
    [No Abstract]   [Full Text] [Related]  

  • 13. Living donor liver transplantation and hepatitis C: lessons from the learning curve?
    Carrión JA; Forns X
    Liver Transpl; 2007 Jan; 13(1):18-20. PubMed ID: 17192905
    [No Abstract]   [Full Text] [Related]  

  • 14. Liver transplantation: problems and perspectives.
    Fevery J
    Hepatogastroenterology; 1998; 45(22):1039-44. PubMed ID: 9756004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of hepatitis C virus RNA-positive donor liver for transplant to hepatitis C virus RNA-negative recipient.
    Saberi B; Hamilton JP; Durand CM; Li Z; Philosophe B; Cameron AM; Sulkowski MS; Gurakar A
    Liver Transpl; 2018 Jan; 24(1):140-143. PubMed ID: 28779557
    [No Abstract]   [Full Text] [Related]  

  • 16. Would patients with hepatitis C virus on the waiting list for a liver transplant accept a hepatitis C-positive organ?
    Martínez-Alarcón L; Rios A; Ramírez P; Parrilla P
    Transpl Infect Dis; 2009 Oct; 11(5):475-6. PubMed ID: 19804482
    [No Abstract]   [Full Text] [Related]  

  • 17. Virologically compromised donor grafts in liver transplantation.
    Gallegos-Orozco JF; Vargas HE; Rakela J
    J Hepatol; 2004 Oct; 41(4):512-21. PubMed ID: 15464230
    [No Abstract]   [Full Text] [Related]  

  • 18. Should splenectomy be performed for hepatitis C patients undergoing living-donor liver transplantation?
    Tashiro H; Itamoto T; Ohdan H; Fudaba Y; Kohashi T; Amano H; Ishiyama K; Takahashi S; Aikata H; Chayama K; Arihiro K; Asahara T
    J Gastroenterol Hepatol; 2007 Jun; 22(6):959-60. PubMed ID: 17565657
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased donor risk: who should bear the burden?
    Feng S
    Liver Transpl; 2009 Jun; 15(6):570-3. PubMed ID: 19479799
    [No Abstract]   [Full Text] [Related]  

  • 20. MELD score for selection of patients to receive a left liver graft.
    Sugawara Y; Makuuchi M; Kaneko J; Kokudo N
    Transplantation; 2003 Feb; 75(4):573-4. PubMed ID: 12605135
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.